Cambridge biotech acquired for $53M following move from Philadelphia

Renovacor Inc., a Cambridge-based gene therapy company that relocated from Philadelphia earlier this year, is set to be acquired by New Jersey firm Rocket Pharmaceuticals Inc.

Previous During second quarter, net income falls for banks in Wisconsin, nationally
Next Aurora company to distribute vision-enhancing glasses for veterans

No Comment

Leave a reply

Your email address will not be published.